Dexxos Participações (DEXP3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
27 Aug, 2026Executive summary
Net revenue in 3Q24 reached R$494.1 million, up 12.6% sequentially and 20.1% year-over-year, driven by strong performance in the chemical segment and higher sales volumes in both main business lines.
Adjusted EBITDA for 3Q24 was R$61.0 million, up 9.2% from 2Q24, with a margin of 12.3%. Adjusted net income was R$38.5 million, up 27.6% sequentially, reflecting improved operational efficiency and margin expansion, but down year-over-year due to steel segment pressure.
Cash position exceeded total debt by R$47.0 million at quarter-end, reflecting a robust capital structure and disciplined financial management.
Completed full incorporation of Apolo and GPC Química subsidiaries and launched a share buyback program for 4.1 million shares.
Strategic investments included the launch of a new specialty chemicals unit and ongoing innovation projects in both segments.
Financial highlights
Gross profit in 3Q24 was R$91.7 million, up 10.1% sequentially and 20.1% year-over-year; gross margin was 18.6%.
9M24 net revenue was R$1,321.0 million, stable year-over-year; 9M24 adjusted EBITDA was R$194.6 million, down 16.5% from 9M23, mainly due to weaker steel segment results.
3Q24 adjusted EBITDA margin was 12.3%, and adjusted net margin was 7.8%.
Net cash position improved 69% year-over-year to R$47.0 million.
9M24 adjusted net profit was R$109.0 million, down 13.7% year-over-year.
Outlook and guidance
Management continues to focus on portfolio diversification, operational efficiency, and disciplined capital allocation, with investments in new chemical specialties and innovation in both segments.
Strategic investments in new production capacity and technology are expected to support future growth, especially in the chemical segment.
Ongoing share conversion process pending due to lack of quorum.
Latest events from Dexxos Participações
- Robust growth, expanded capacity, and strong ESG practices drive leadership in core markets.DEXP3
Corporate presentation - Revenue and profit fell, but chemicals growth and strong cash position support diversification.DEXP3
Q2 2024 - Revenue up 3.7% to R$1.81B, but EBITDA and net income fell amid margin and steel segment pressure.DEXP3
Q4 2024 - Net revenue rose 55.5% year-over-year to R$603.2 million, with strong growth in both segments.DEXP3
Q1 2025 - Net revenue rose 45.2% and adjusted EBITDA 16.8% year-over-year, with leverage at 0.3x.DEXP3
Q2 2025 - Net revenue up 30% and net income up 11.5% in 9M25, with margins down but cash and investments strong.DEXP3
Q3 2025 - Revenue up 18% to R$2.14B, margins down, strong cash, and new investments executed.DEXP3
Q4 2025 - Sequential margin gains and strong cash offset year-over-year revenue declines.DEXP3
Q1 2026 - Margins and net income improved despite lower revenue, with strong cash and new investments.DEXP3
Q2 2026